Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pan Liu

Showing results (1191-1200 of 1,207) with videos related to

Pageof 121
Sort By:
Brain : a Journal of Neurology|October 24, 2024
Radiosurgery versus observation for brainstem cavernous malformations: a 5-year multicentre cohort studyDa Li, Jian-Cong Weng, Shi-Bin Sun, et al.
Cell Host & Microbe|October 21, 2022
Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75Yunlong Cao, Weiliang Song, Lei Wang, et al.
Journal of Global Antimicrobial Resistance|July 21, 2021
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017-2020Ying-Chun Chien, Yu-Lin Lee, Po-Yu Liu, et al.
International Journal of Antimicrobial Agents|June 17, 2019
Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018Yu-Lin Lee, Min-Chi Lu, Pei-Lan Shao, et al.
International Journal of Antimicrobial Agents|June 24, 2021
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017-2020Yu-Lin Lee, Wen-Chien Ko, Wen-Sen Lee, et al.
Nature|January 28, 2022
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variantsKang Wang, Zijing Jia, Linilin Bao, et al.
BMJ (Clinical Research Ed.)|March 20, 2026
Effect of a clinical decision support system on stroke care quality and outcomes in patients with acute ischaemic stroke (GOLDEN BRIDGE II): cluster randomised clinical trialXinmiao Zhang, Lingling Ding, Jing Jing, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 15, 2021
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018-2020Po-Yu Liu, Wen-Chien Ko, Wen-Sen Lee, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 5, 2021
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019Yu-Te Tsai, Yu-Lin Lee, Min-Chi Lu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 13, 2025
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients with Active Ankylosing Spondylitis: Results from an Adaptive Seamless Phase II/III TrialXu Liu, Liling Xu, Cheng Zhao, et al.
Pageof 121

Showing results (1191-1200 of 1,207) with videos related to

Sort By:
Pageof 121
Brain : a Journal of Neurology|October 24, 2024
Radiosurgery versus observation for brainstem cavernous malformations: a 5-year multicentre cohort studyDa Li, Jian-Cong Weng, Shi-Bin Sun, et al.
Cell Host & Microbe|October 21, 2022
Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75Yunlong Cao, Weiliang Song, Lei Wang, et al.
Journal of Global Antimicrobial Resistance|July 21, 2021
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017-2020Ying-Chun Chien, Yu-Lin Lee, Po-Yu Liu, et al.
International Journal of Antimicrobial Agents|June 17, 2019
Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018Yu-Lin Lee, Min-Chi Lu, Pei-Lan Shao, et al.
International Journal of Antimicrobial Agents|June 24, 2021
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017-2020Yu-Lin Lee, Wen-Chien Ko, Wen-Sen Lee, et al.
Nature|January 28, 2022
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variantsKang Wang, Zijing Jia, Linilin Bao, et al.
BMJ (Clinical Research Ed.)|March 20, 2026
Effect of a clinical decision support system on stroke care quality and outcomes in patients with acute ischaemic stroke (GOLDEN BRIDGE II): cluster randomised clinical trialXinmiao Zhang, Lingling Ding, Jing Jing, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 15, 2021
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018-2020Po-Yu Liu, Wen-Chien Ko, Wen-Sen Lee, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 5, 2021
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019Yu-Te Tsai, Yu-Lin Lee, Min-Chi Lu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 13, 2025
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients with Active Ankylosing Spondylitis: Results from an Adaptive Seamless Phase II/III TrialXu Liu, Liling Xu, Cheng Zhao, et al.
Pageof 121